Are There Fewer Side Effects With Wegovy Than People Expect?

The biggest misconception: that side effects are rare with Wegovy

The most common thing people get wrong is expecting Wegovy to be well-tolerated from day one. The myth runs in two directions, some believe it causes constant, unbearable nausea; others assume they will sail through with no issues at all. Neither picture is typical. What the clinical evidence actually shows is that side effects are common, particularly in the early weeks, but are usually mild to moderate and improve as the body adapts to each dose level.

In the STEP 1 trial (68 weeks, over a thousand adults with obesity) nausea was reported by around 44% of participants on semaglutide 2.4mg, compared with around 16% on placebo. Diarrhoea, vomiting and constipation were also more frequent in the treatment group. Crucially though, the vast majority of those effects were rated mild or moderate in intensity, and the proportion reporting them fell substantially after the titration period ended. This is the part people tend not to hear. Published in the New England Journal of Medicine, those findings remain the strongest single-trial evidence base for semaglutide 2.4mg.

Slow, stepwise dose increases exist precisely because starting at the maintenance dose would be poorly tolerated by most people. The titration ladder (moving through lower doses before reaching 2.4mg) is designed to give the gut time to adjust. People who skip steps or increase too quickly are more likely to experience prolonged symptoms. That structure matters.

What Wegovy's side effects actually look like in practice

The GI-led pattern is well-established: nausea and burping are most common early on, constipation tends to affect people during slower weeks between dose changes, and looser stools or indigestion can come and go. Fatigue and headache appear in a smaller proportion of users, typically in the first few weeks. Injection-site redness or mild bruising is possible but generally brief.

A question our prescribers hear most weeks is whether Wegovy has less side effects for some people than others, and the honest answer is that individual tolerability varies considerably depending on dose stage, diet and digestive history. Eating smaller portions, avoiding fatty or heavily spiced food, and not lying flat straight after injecting all tend to help. These are practical strategies rather than treatments, and our prescribers talk through them as part of the initial consultation.

For detail on managing symptoms day to day, the practical guidance on coping with Wegovy side effects covers the strategies most people find useful. And if you want to understand what other people on Wegovy actually report experiencing, the reported side effects in real-world use page adds useful context alongside the trial data.

It is also worth being clear that Wegovy carries a Black Triangle (▼) designation from the MHRA, meaning it is still under additional post-market monitoring. That is standard for newer medicines and does not mean it is unsafe, but it does mean the evidence base continues to grow.

When to get medical help, side effects that cannot wait

Most Wegovy side effects can be managed at home or with a call to your prescribing team. A few cannot. Seek urgent medical attention if you develop severe, persistent stomach pain, especially pain that radiates through to the back, with or without vomiting. That is the key warning sign for acute pancreatitis, which the MHRA's January 2026 Drug Safety Update on GLP-1 medicines specifically flagged as an infrequent but serious risk requiring prompt assessment.

Other symptoms that need prompt attention include signs of a serious allergic reaction (swollen face, throat or tongue, difficulty breathing), symptoms of gallbladder problems (sharp upper-right abdominal pain, fever, yellowing skin), or significant dehydration from vomiting or diarrhoea, particularly if you cannot keep fluids down for more than a day. Low mood or any thoughts of self-harm should always prompt contact with a healthcare professional immediately.

If you want a fuller picture of potential longer-term considerations, the long-term side effects of Wegovy page addresses what current evidence does and does not yet tell us about extended use. Any suspected side effect can also be reported directly through the MHRA's Yellow Card scheme, patient reports genuinely contribute to post-marketing safety surveillance.

How individual factors shape your experience

Side effects are not one-size-fits-all. Age, existing digestive conditions, speed of titration and what you eat on injection day can all influence tolerability. People with a history of nausea-prone digestion or anxiety around food often find the early weeks harder. Those who have had pancreatitis before, or who are pregnant, breastfeeding or trying to conceive, are among those for whom Wegovy is not recommended, and that is part of why a clinical assessment matters before any prescription is issued.

The broader Wegovy side effects overview covers the full profile across all dose levels, and for those asking whether Wegovy tends to produce fewer side effects at certain dose stages, the weight-loss treatment options page gives useful context alongside a comparison of how semaglutide's tolerability picture sits relative to other treatments. At nume, our prescribers are available seven days a week for aftercare, so if something does not feel right once you have started, there is a clinical team to contact, not just an FAQ page. You can also read about our clinical approach on the clinical team page.

If you are ready to talk through your own situation, our prescribers cover tolerability, your health history and what to expect as part of every free consultation.